Touyun Biotech Group Limited (1332.HK)
HKD 0.18
(-7.22%)
HKD 0.18
(-7.22%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -15.6 Million | -26.37 Million | -53.81 Million | -15.34 Million | -204.94 Million | -117.11 Million |
| Net Income | -268.93 Million | -199.18 Million | -122.97 Million | -171.98 Million | -194.89 Million | -251.97 Million |
| Depreciation & Amortization | 36.58 Million | 33.13 Million | 22.7 Million | 28.44 Million | 31.58 Million | 28.5 Million |
| Deferred income taxes | - | - | 36.34 Million | 58.14 Million | 126.91 Million | 74.94 Million |
| Stock-based compensation | 2.58 Million | 6.85 Million | 16.18 Million | 4.26 Million | 15.13 Million | 15.87 Million |
| Change in working capital | 17.02 Million | -19.39 Million | -23.03 Million | 35.32 Million | -197.91 Million | -2.02 Million |
| Other non-cash items | 255.87 Million | 152.21 Million | 16.97 Million | 30.46 Million | 14.23 Million | 17.55 Million |
| Investing Cash Flow | -64.94 Million | -17.24 Million | -147.73 Million | -47.86 Million | 155.83 Million | -28.78 Million |
| Investments in PPE | -17.13 Million | -12.93 Million | -250.79 Million | -125.51 Million | -7.64 Million | -36.21 Million |
| Acquisitions | 7.18 Million | 8.14 Million | 152.07 Million | 32.79 Million | 1.5 Million | 2.82 Million |
| Investment purchases | -55 Million | -5.46 Million | -52.3 Million | - | -48.96 Million | -120.2 Million |
| Sales/Maturities of investments | - | -8.14 Million | - | 42.12 Million | 10.92 Million | 115.95 Million |
| Other Investing Activities | -53.81 Million | 1.14 Million | 3.27 Million | 2.73 Million | 200 Million | 8.85 Million |
| Financing Cash Flow | -33.67 Million | 102.63 Million | 123.17 Million | 160.47 Million | -7.25 Million | -108.17 Million |
| Debt repayment | -23.82 Million | -214.94 Million | -120.85 Million | -98.05 Million | -3.27 Million | -105.83 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 31.26 Million | 119.84 Million | - | - |
| Other Financing Activities | 6.51 Million | 317.57 Million | 212.76 Million | 138.68 Million | -3.98 Million | -2.34 Million |
| Accounts receivables | 24.51 Million | -8.54 Million | -74.28 Million | -25.88 Million | -61.17 Million | 13.73 Million |
| Accounts payables | -10.71 Million | -25.6 Million | 34.86 Million | 12.15 Million | -9.88 Million | 7.31 Million |
| Inventory | 3.22 Million | -2.84 Million | 975 Thousand | 2.19 Million | 7.71 Million | -11.76 Million |
| Other working capital | 18.54 Million | 17.6 Million | 15.4 Million | 46.86 Million | -134.57 Million | -11.3 Million |
| Cash at beginning of period | 128.09 Million | 60.19 Million | 142.44 Million | 40.45 Million | 97.51 Million | 348.65 Million |
| Cash at end of period | 34.49 Million | 128.09 Million | 60.19 Million | 142.44 Million | 40.45 Million | 97.51 Million |
| Capital Expenditure | -17.13 Million | -12.93 Million | -250.79 Million | -125.51 Million | -7.64 Million | -36.21 Million |
| Effect of forex changes on cash | 1.37 Million | 8.88 Million | -3.86 Million | 4.72 Million | -690 Thousand | 2.93 Million |
| Net cash flow / Change in cash | -93.6 Million | 67.9 Million | -82.24 Million | 101.98 Million | -57.05 Million | -251.14 Million |
| Free Cash Flow | -32.73 Million | -39.3 Million | -304.6 Million | -140.86 Million | -212.58 Million | -153.33 Million |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -47.96 Million | -268.93 Million | -184.98 Million | -83.95 Million | -199.18 Million | -109.99 Million |
| Depreciation & Amortization | 17.14 Million | 36.58 Million | 25.7 Million | 10.88 Million | 33.13 Million | 19.97 Million |
| Deferred income taxes | - | - | - | - | - | -50.53 Million |
| Stock-based compensation | 1.62 Million | 2.58 Million | -1.97 Million | 4.56 Million | 6.85 Million | -1.99 Million |
| Change in working capital | - | 17.02 Million | 27.73 Million | - | -19.39 Million | -11.39 Million |
| Other non-cash items | -6.36 Million | 255.87 Million | 123.92 Million | 108.07 Million | 152.21 Million | 147.89 Million |
| Investing Cash Flow | -910 Thousand | -64.94 Million | -14.78 Million | -56.15 Million | -17.24 Million | -9.59 Million |
| Investments in PPE | -1.35 Million | -17.13 Million | -15.97 Million | -1.15 Million | -12.93 Million | -11.05 Million |
| Acquisitions | 442 Thousand | 7.18 Million | 7.18 Million | - | 8.14 Million | 6.92 Million |
| Investment purchases | - | -55 Million | - | -55 Million | -5.46 Million | -5.46 Million |
| Sales/Maturities of investments | - | - | - | - | -8.14 Million | 5.71 Million |
| Other Investing Activities | 442 Thousand | -53.81 Million | 1.18 Million | -55 Million | 1.14 Million | -5.71 Million |
| Financing Cash Flow | 15.52 Million | -33.67 Million | 16.79 Million | -44.47 Million | 102.63 Million | 60.97 Million |
| Debt repayment | -9.97 Million | -23.82 Million | -10.85 Million | -34.67 Million | -214.94 Million | -59.94 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 5.54 Million | 6.51 Million | 16.79 Million | -1.08 Million | 317.57 Million | 9.75 Million |
| Accounts receivables | - | 24.51 Million | 5.97 Million | - | -8.54 Million | 15.42 Million |
| Accounts payables | - | -10.71 Million | - | - | -25.6 Million | - |
| Inventory | - | 3.22 Million | 3.22 Million | - | -2.84 Million | -2.84 Million |
| Other working capital | - | 18.54 Million | 18.54 Million | - | 17.6 Million | -23.97 Million |
| Cash at beginning of period | 34.49 Million | 128.09 Million | 40.14 Million | 128.09 Million | 60.19 Million | 35.04 Million |
| Cash at end of period | 13.75 Million | 34.49 Million | 34.49 Million | 40.14 Million | 128.09 Million | 128.09 Million |
| Capital Expenditure | -1.35 Million | -17.13 Million | -15.97 Million | -1.15 Million | -12.93 Million | -11.05 Million |
| Effect of forex changes on cash | 219 Thousand | 1.37 Million | 1.93 Million | -566 Thousand | 8.88 Million | 6.16 Million |
| Net cash flow / Change in cash | -20.73 Million | -93.6 Million | -5.65 Million | -87.95 Million | 67.9 Million | 93.05 Million |
| Free Cash Flow | -36.91 Million | -32.73 Million | -25.57 Million | 12.08 Million | -39.3 Million | 6.86 Million |
8616
JEXYF
HOCPF
6227
DFILF
7957